Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 3 of 3 citing Sears: Anti-vascular endothelial growth factor and retinopathy of prematurity. (0.08 sec) 

Emerging Treatments for Retinopathy of Prematurity


IS Mantagos, DK Vanderveen, LEH Smith - Seminars in Ophthalmology, 2009 - informahealthcare.com
Retinopathy or prematurity (ROP) is a leading cause of potentially preventable
blindness in children. With increased survival of infants born at earlier
gestational ages the number of infants at risk from vision loss from ROP ...
Cited by 1 - Related articles - All 5 versions

Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity


MSJ Blundell, LP Hunt, EJ Mayer, AD Dick, JM … - Br J Ophthalmol, 2009 - pt.wkhealth.com
MSJ Blundell,1 LP Hunt,2 EJ Mayer,1 AD Dick,1 JM Sparrow3,4 1 Academic Unit of
Ophthalmology, University of Bristol and Bristol Eye Hospital, Clinical Research
Unit, Bristol, UK; 2 Department of Clinical Sciences South Bristol, ...

Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity


BA Darlow, C Gilbert, GE Quinn, R Azad, AL … - British Medical Journal, 2009 - bjo.bmj.com
MSJ Blundell, 1 LP Hunt, 2 EJ Mayer, 1 AD Dick, 1 JM Sparrow 3,4 1 Academic Unit
of Ophthalmology, University of Bristol and Bristol Eye Hospital, Clinical
Research Unit, Bristol, UK; 2 Department of Clinical Sciences South ...
Related articles - All 4 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google